130 related articles for article (PubMed ID: 6974710)
1. Use of Orthoclone monoclonal antibodies in the study of selected dermatologic conditions.
Berger CL; Kung P; Goldstein G; DePietro W; Takezaki S; Chu A; Fithian E; Edelson RL
Int J Immunopharmacol; 1981; 3(3):275-82. PubMed ID: 6974710
[TBL] [Abstract][Full Text] [Related]
2. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
Schmitt D; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
[TBL] [Abstract][Full Text] [Related]
3. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
Faure M; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous T cell lymphoma: characterization by monoclonal antibodies.
Kung PC; Berger CL; Goldstein G; LoGerfo P; Edelson RL
Blood; 1981 Feb; 57(2):261-6. PubMed ID: 6160893
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic use of monoclonal antibodies in a variety of dermatologic conditions.
Berger CL; Chu A; Fithian E; Patterson J; Edelson RL
Am J Dermatopathol; 1983 Feb; 5(1):85-94. PubMed ID: 6222665
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates.
Haynes BF; Hensley LL; Jegasothy BV
Blood; 1982 Aug; 60(2):463-73. PubMed ID: 7046848
[TBL] [Abstract][Full Text] [Related]
7. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells.
Haynes BF; Metzgar RS; Minna JD; Bunn PA
N Engl J Med; 1981 May; 304(22):1319-23. PubMed ID: 6971410
[TBL] [Abstract][Full Text] [Related]
9. Blood and lymph node T-lymphocyte subsets in non-Hodgkin lymphomas.
Lindemalm C; Mellstedt H; Biberfeld P; Björkholm M; Christensson B; Holm G; Johansson B; Sundblad R
Scand J Haematol; 1983 Jan; 30(1):68-78. PubMed ID: 6601285
[TBL] [Abstract][Full Text] [Related]
10. Antigenic modulation of pan-T-cell and T-cell subset-specific markers.
Estabrook A; Mittler R; LoGerfo P; Hardy M; Edelson RL; Berger CL
Diagn Immunol; 1983; 1(3):199-204. PubMed ID: 6209055
[TBL] [Abstract][Full Text] [Related]
11. [Adult T-cell leukemia/lymphoma with OKT4 lack of OKT8 in peripheral blood and with OKT4 and OKT8 in lymph node. Study of two color flow cytometry].
Furukawa Y; Inoue T; Yamane T; Hiyoshi M; Sasaki A; Kishida T; Kojima K; Im T; Tatsumi N; Okuda K
Rinsho Byori; 1989 Jul; 37(7):830-4. PubMed ID: 2532690
[TBL] [Abstract][Full Text] [Related]
12. Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome.
Fox RI; Carstens SA; Fong S; Robinson CA; Howell F; Vaughan JH
Arthritis Rheum; 1982 Apr; 25(4):419-26. PubMed ID: 6978718
[TBL] [Abstract][Full Text] [Related]
13. The cell population in the cutaneous infiltrate of mycosis fungoides: in situ using monoclonal antisera.
Holden CA; Morgan EW; MacDonald DM
Br J Dermatol; 1982 Apr; 106(4):385-92. PubMed ID: 6462163
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies.
Keystone EC; Lau C; Gladman DD; Wilkinson S; Lee P; Shore A
Clin Exp Immunol; 1982 May; 48(2):443-8. PubMed ID: 6213329
[TBL] [Abstract][Full Text] [Related]
15. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
16. Molecular identification of human T-lymphocyte antigens defined by the OKT5 and OKT8 monoclonal antibodies.
Phan-Dinh-Tuy F; Niaudet P; Bach JF
Mol Immunol; 1982 Dec; 19(12):1649-54. PubMed ID: 6761583
[TBL] [Abstract][Full Text] [Related]
17. Cell surface phenotype and in vitro function of adult T-cell leukemia cells.
Uchiyama T; Hattori T; Wano Y; Tsudo M; Takatsuki K; Uchino H
Diagn Immunol; 1983; 1(3):150-4. PubMed ID: 6094084
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.
Platsoucas CD; Good RA
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866
[TBL] [Abstract][Full Text] [Related]
19. [Sub-populations of T helper suppressor lymphocytes in diverse dermatoses using monoclonal antibodies. Preliminary results (author's transl)].
Fulton R; Thivolet J; Garcier F; Gaucherand M
Ann Dermatol Venereol; 1981; 108(3):243-6, 249-50. PubMed ID: 6455084
[TBL] [Abstract][Full Text] [Related]
20. OKT3 induces suppressor cells for mixed lymphocyte and PHA mitogenic responses in human peripheral lymphocytes.
Lau C; Goldstein G
Int J Immunopharmacol; 1981; 3(3):187-92. PubMed ID: 6457004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
